|
| | 09900SB1466sam001 | - 2 - | LRB099 09990 MLM 32728 a |
|
|
1 | | contrary, a licensed pharmacist may dispense an opioid |
2 | | antagonist in accordance with written, standardized procedures |
3 | | or protocols developed by the Department with the Department of |
4 | | Public Health and the Department of Human Services, if such |
5 | | procedures or protocols are filed at the pharmacist's place of |
6 | | practice and with the Board before implementation. |
7 | | (c) A health care practitioner may prescribe naloxone |
8 | | antidotes in the name of a licensed pharmacist for use in |
9 | | accordance with this Act, and pharmacists may dispense opioid |
10 | | antidotes pursuant to a prescription issued in the name of an |
11 | | authorized entity. Such prescriptions shall be valid for a |
12 | | period of 2 years. |
13 | | (d) Before dispensing an opioid antidote pursuant to this |
14 | | Section, a pharmacist shall complete a training program |
15 | | approved by the Department of Human Services pursuant to |
16 | | Section 5-23 of the Alcoholism and Other Drug Abuse and |
17 | | Dependency Act. The training program shall include, but not be |
18 | | limited to, proper documentation and quality assurance. |
19 | | (e) For the purpose of this Section: |
20 | | "Health care practitioner" means a physician licensed to |
21 | | practice medicine in all its branches, dentist, veterinarian, |
22 | | podiatric physician, optometrist, physician assistant, or an |
23 | | advanced practice nurse. |
24 | | "Opioid antidote" means a dose of naloxone hydrochloride or |
25 | | any other similarly acting and equally safe drug approved by |
26 | | the United States Food and Drug Administration.
|